Vincenzo Cerundolo
Vincenzo Cerundolo was a renowned Italian-British medical researcher known for his groundbreaking work in the field of immunology, particularly his significant contributions to our understanding of the human immune response.
Early Life and Education[edit | edit source]
Vincenzo Cerundolo was born in Italy and pursued his education in Medicine at the University of Naples. His passion for science and research led him to the United Kingdom, where he furthered his studies and made significant contributions to the field of immunology.
Career and Contributions[edit | edit source]
Cerundolo's work focused on understanding how the immune system recognises and responds to cancer cells. His notable career included being the Director of the MRC Human Immunology Unit at the Weatherall Institute of Molecular Medicine, University of Oxford, where he led a team of researchers dedicated to exploring the complex workings of the human immune system.
His pioneering work in studying the presentation of antigenic peptides on major histocompatibility complex (MHC) molecules and the T cell response played a crucial role in the field of tumour immunology. This led to advancements in the development of cancer immunotherapies, which harness the body's immune system to fight against cancer cells.
Legacy[edit | edit source]
Cerundolo's untimely death in 2020 was a great loss to the scientific community. His contributions to the field of immunology, specifically to cancer immunotherapy, have been widely acknowledged, and his work continues to inform ongoing research in the field.
Awards and Honors[edit | edit source]
In recognition of his outstanding contributions to the field of immunology, Cerundolo received numerous awards and honours throughout his career. These include the prestigious Feldberg Foundation Prize and the King Faisal International Prize for Medicine.
| Vincenzo Cerundolo Resources | |
|---|---|
|
 |
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
